RN3161
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RN3161, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity [Phase 1, Phase 2]